Xlife Sciences AG

Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025

Xlife Sciences AG enables international co-investors to enter the stock and is planning a dual listing on the London Stock Exchange Group (LSEG)

Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures

Xlife Sciences AG Completes Strategic Review Process by Q3 2024

Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report

Xlife Sciences AG Publishes 2023 Annual Report